Free Trial

Histogen (HSTO) Competitors

Histogen logo
$0.0002 0.00 (0.00%)
As of 10/22/2025

HSTO vs. AMPE, CMRA, EFTR, PXMD, ATNFW, LBPSW, AIMDW, ALVOW, ARAV, and ACABW

Should you be buying Histogen stock or one of its competitors? The main competitors of Histogen include Ampio Pharmaceuticals (AMPE), Comera Life Sciences (CMRA), eFFECTOR Therapeutics (EFTR), PaxMedica (PXMD), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), and Atlantic Coastal Acquisition Corp. II (ACABW). These companies are all part of the "pharmaceutical products" industry.

Histogen vs. Its Competitors

Ampio Pharmaceuticals (NYSE:AMPE) and Histogen (NASDAQ:HSTO) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

Ampio Pharmaceuticals has higher earnings, but lower revenue than Histogen. Ampio Pharmaceuticals is trading at a lower price-to-earnings ratio than Histogen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ampio PharmaceuticalsN/AN/A-$8.63M-$11.010.00
Histogen$19K0.04-$10.62M-$2.810.00

In the previous week, Ampio Pharmaceuticals' average media sentiment score of 0.00 equaled Histogen'saverage media sentiment score.

Company Overall Sentiment
Ampio Pharmaceuticals Neutral
Histogen Neutral

5.7% of Ampio Pharmaceuticals shares are held by institutional investors. 3.3% of Ampio Pharmaceuticals shares are held by company insiders. Comparatively, 3.3% of Histogen shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Ampio Pharmaceuticals has a beta of 5.13, suggesting that its share price is 413% more volatile than the S&P 500. Comparatively, Histogen has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500.

Company Net Margins Return on Equity Return on Assets
Ampio PharmaceuticalsN/A N/A N/A
Histogen N/A N/A N/A

Summary

Ampio Pharmaceuticals and Histogen tied by winning 3 of the 6 factors compared between the two stocks.

Get Histogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for HSTO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSTO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

HSTO vs. The Competition

MetricHistogenPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$1.02B$6.14B$10.76B
Dividend YieldN/A4.84%5.71%4.83%
P/E Ratio0.001.3429.8028.54
Price / Sales0.04165.12499.08189.72
Price / CashN/A17.6336.6160.67
Price / Book0.007.7012.016.60
Net Income-$10.62M-$7.58M$3.32B$276.82M
7 Day PerformanceN/A1.62%1.59%1.99%
1 Month PerformanceN/A26.46%6.15%2.56%
1 Year PerformanceN/A-14.24%61.11%32.85%

Histogen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HSTO
Histogen
N/A$0.00
flat
N/A-99.9%$1K$19K0.0020
AMPE
Ampio Pharmaceuticals
N/A$0.00
+14.8%
N/A+40.9%$4KN/A0.0020Gap Up
CMRA
Comera Life Sciences
N/AN/AN/AN/A$3K$1.00M0.002
EFTR
eFFECTOR Therapeutics
0.1789 of 5 stars
$0.00
flat
N/A-83.3%$1KN/A0.0010Upcoming Earnings
PXMD
PaxMedica
N/A$0.00
flat
N/A-99.9%$1KN/A0.002
ATNFW
180 Life Sciences
N/A$0.04
-5.0%
N/A+264.5%$0.00N/A0.007Gap Up
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AIMDW
Ainos
N/A$0.15
-15.3%
N/AN/A$0.00$110.87K0.0040
ALVOW
Alvotech
N/A$1.82
+7.7%
N/A-39.3%$0.00$560.10M0.004Gap Down
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
-5.7%
N/A-47.8%$0.00N/A0.0015

Related Companies and Tools


This page (NASDAQ:HSTO) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners